ABOS — Acumen Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Acumen Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.55	43.8	194	178	244
Net Total Receivables	0.03	0.109	0	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7.18	44.4	199	180	247
Net Property, Plant And Equipment	—	—	0.036	0.27	0.503
Long Term Investments
Other Long Term Assets
Total Assets	7.32	44.4	230	197	310
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.34	6.37	5.15	7.81	13
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.34	6.37	5.15	7.81	43.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	5.98	38.1	225	189	267
Total Liabilities & Shareholders' Equity	7.32	44.4	230	197	310
Total Common Shares Outstanding